Takeda Pharmaceutical Co Stock Price Prediction
| TAK Stock | USD 14.36 0.28 1.99% |
Momentum 53
Impartial
Oversold | Overbought |
Quarterly Earnings Growth (0.78) | Wall Street Target Price 16.3603 | Quarterly Revenue Growth 0.03 |
Using Takeda Pharmaceutical hype-based prediction, you can estimate the value of Takeda Pharmaceutical Co from the perspective of Takeda Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Takeda Pharmaceutical using Takeda Pharmaceutical's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Takeda using crowd psychology based on the activity and movement of Takeda Pharmaceutical's stock price.
Takeda Pharmaceutical Short Interest
An investor who is long Takeda Pharmaceutical may also wish to track short interest. As short interest increases, investors should be becoming more worried about Takeda Pharmaceutical and may potentially protect profits, hedge Takeda Pharmaceutical with its derivative instruments, or be ready for some potential downside.
200 Day MA 13.7064 | Short Percent 0.0012 | Short Ratio 1.81 | Shares Short Prior Month 4.9 M | 50 Day MA 13.3278 |
Takeda Pharmaceutical Hype to Price Pattern
Investor biases related to Takeda Pharmaceutical's public news can be used to forecast risks associated with an investment in Takeda. The trend in average sentiment can be used to explain how an investor holding Takeda can time the market purely based on public headlines and social activities around Takeda Pharmaceutical Co. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Takeda Pharmaceutical's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Takeda Pharmaceutical.
Takeda Pharmaceutical Implied Volatility | 1.25 |
Takeda Pharmaceutical's implied volatility exposes the market's sentiment of Takeda Pharmaceutical Co stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Takeda Pharmaceutical's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Takeda Pharmaceutical stock will not fluctuate a lot when Takeda Pharmaceutical's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Takeda Pharmaceutical to buy its stock at a price that has no basis in reality. In that case, they are not buying Takeda because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Takeda Pharmaceutical after-hype prediction price | USD 14.36 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Takeda contract
Based on the Rule 16, the options market is currently suggesting that Takeda Pharmaceutical Co will have an average daily up or down price movement of about 0.0781% per day over the life of the 2025-04-17 option contract. With Takeda Pharmaceutical trading at USD 14.36, that is roughly USD 0.0112 . If you think that the market is fully incorporating Takeda Pharmaceutical's daily price movement you should consider acquiring Takeda Pharmaceutical Co options at the current volatility level of 1.25%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Takeda |
Takeda Pharmaceutical After-Hype Price Prediction Density Analysis
As far as predicting the price of Takeda Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Takeda Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Takeda Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Takeda Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting Takeda Pharmaceutical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Takeda Pharmaceutical's historical news coverage. Takeda Pharmaceutical's after-hype downside and upside margins for the prediction period are 13.15 and 15.57, respectively. We have considered Takeda Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Takeda Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of Takeda Pharmaceutical is based on 3 months time horizon.
Takeda Pharmaceutical Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Takeda Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Takeda Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Takeda Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.10 | 1.22 | 0.01 | 0.01 | 10 Events / Month | 11 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
14.36 | 14.36 | 0.00 |
|
Takeda Pharmaceutical Hype Timeline
On the 26th of February Takeda Pharmaceutical is traded for 14.36. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.01. Takeda is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.1%. %. The volatility of related hype on Takeda Pharmaceutical is about 924.24%, with the expected price after the next announcement by competition of 14.35. The company has price-to-book ratio of 0.9. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Takeda Pharmaceutical has Price/Earnings To Growth (PEG) ratio of 1.59. The entity last dividend was issued on the 30th of September 2024. Considering the 90-day investment horizon the next forecasted press release will be in about 10 days. Check out Takeda Pharmaceutical Basic Forecasting Models to cross-verify your projections.Takeda Pharmaceutical Related Hype Analysis
Having access to credible news sources related to Takeda Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Takeda Pharmaceutical's future price movements. Getting to know how Takeda Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Takeda Pharmaceutical may potentially react to the hype associated with one of its peers.
Takeda Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Takeda price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Takeda using various technical indicators. When you analyze Takeda charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Takeda Pharmaceutical Predictive Indicators
The successful prediction of Takeda Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Takeda Pharmaceutical Co, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Takeda Pharmaceutical based on analysis of Takeda Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Takeda Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Takeda Pharmaceutical's related companies. | 2022 | 2024 | 2025 (projected) | Dividend Yield | 0.0414 | 0.0397 | 0.0417 | Price To Sales Ratio | 1.68 | 1.75 | 1.67 |
Story Coverage note for Takeda Pharmaceutical
The number of cover stories for Takeda Pharmaceutical depends on current market conditions and Takeda Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Takeda Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Takeda Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Takeda Pharmaceutical Short Properties
Takeda Pharmaceutical's future price predictability will typically decrease when Takeda Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Takeda Pharmaceutical Co often depends not only on the future outlook of the potential Takeda Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Takeda Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.6 B | |
| Cash And Short Term Investments | 457.8 B |
Check out Takeda Pharmaceutical Basic Forecasting Models to cross-verify your projections. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Takeda Pharmaceutical. If investors know Takeda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Takeda Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.78) | Dividend Share 192 | Earnings Share 0.43 | Revenue Per Share | Quarterly Revenue Growth 0.03 |
The market value of Takeda Pharmaceutical is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutical's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Takeda Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Takeda Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.